News Roundup | Pandemic Turnaround in Uttar Pradesh with Dramatic Decline in Cases

Unprecedented Pandemic Turnaround in Uttar Pradesh with Dramatic Decline in CasesThe health authorities for the state of Uttar Pradesh are easing up on COVID-19-based restrictions, at least in zones of the state where SARS-CoV-2 infections now fall below 600 cases. The state was already offering ivermectin as part of a population-wide regimen but the health authorities there doubled down their efforts as India’s national COVID-19 guidelines introduced ivermectin just days before.

Article Link | https://trialsitenews.com/unprecedented-pandemic-turnaround-in-uttar-pradesh-with-dramatic-decline-in-cases-time-to-smell-the-coffee/

University of Minnesota ‘COVID-OUT’ Factorial Trial Investigates Potential of Ivermectin, Fluvoxamine & Metformin for Early Onset Mild-to-Moderate COVID-19The University of Minnesota recently added generic study drugs to critically important yet not widely known clinical trial investigating outpatient treatment for SARS-CoV-2 infection, the virus behind COVID-19. The study, led by Carolyn Bramante called The COVIDOUT clinical trial targets an incredibly important segment of the COVID-19 diseases spectrum, which covers approximately 90% of the total ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee